Results 81 to 90 of about 2,317 (166)

Six-minute walk test: prognostic value and effects of nebivolol versus placebo in elderly patients with heart failure from the SENIORS trial

, 2020
Marcelo C. Shibata, Jordan Curl-Roper, Dirk J. van Veldhuisen, Sy Ha, Andrew J.S. Coats, Marcus Flather   +5 more
openalex   +2 more sources

UEG Week 2025 Poster Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

NEBIVOLOL – ESPECIAL BETA-ADRENOBLOCKER

, 2010
Thomas Münzel, Tommaso Gori
openalex   +2 more sources

The influence of nebivolol on central hemodynamic, platelet aggregation and hypophis-honad system in men arterial hypertension [PDF]

, 2003
M RAKHMATULLAEVA
openalex   +1 more source

Modulation of TNF‐α, interleukin‐6, and interleukin‐10 by nebivolol–valsartan and nebivolol–lisinopril polytherapy in SHR rats [PDF]

Diego Lezama‐Martínez, Jazmín Flores‐Monroy, Diana Ramírez‐Hernández, G. Farina, Salvador Fonseca-Coronado, María Elena Hernández‐Campos   +5 more
openalex   +1 more source

Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy

Кардиоваскулярная терапия и профилактика, 2010
Background: Impaired coronary flow reserve (CFR) is a significant predictor of poor prognosis in patients with idiopathic dilated cardiomyopathy (IDC).
Dogan Erdogan, Hakan Gullu, Mustafa Caliskan, Ozgur Ciftci, Semra Baycan, Aylin Yildirir, Haldun Muderrisoglu   +6 more
doaj  

6.6 COMPARING THE EFFECTS OF NEBIVOLOL VERSUS METOPROLOL SUCCINATE ON CENTRAL HAEMODYNAMICS, FUNCTIONAL-STRUCTURAL CHANGES OF ARTERIES, AND LEFT VENTRICULAR WALL THICKNESS: THE NEMENDAS STUDY

, 2010
Martin Serg, Priit Kampus, Jaak Kals, Maksim Zagura, Piibe Muda, Külliki Karu, Tomi‐Pekka Tuomainen, Mihkel Zilmer, Jaan Eha   +8 more
openalex   +1 more source

Nebivolol in the treatment of chronic heart failure

Vascular Health and Risk Management, 2007
Angie Veverka, Jennifer L SalinasWingate University School of Pharmacy, Wingate, NC, USAAbstract: Nebivolol is a highly selective beta1-adrenergic blocker that also enhances nitric oxide bioavailability via the L-arginine-nitric oxide pathway, leading to
Angie Veverka, Jennifer L Salinas
doaj  

Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place

Кардиоваскулярная терапия и профилактика, 2007
Aim. To optimize chronic heart failure (CHF) pharmacotherapy, basing on endothelin (ET) system activity, functional and cardio-hemodynamic parameters, and their dynamics in beta-adrenoblocker nebivolol therapy. Material and methods. The study included 52
L. I. Olbinskaya, Yu. I. Naymann
doaj  

Nebivolol Treatment Reduces Serum Levels of Asymmetric Dimethylarginine and Improves Endothelial Dysfunction in Essential Hypertensive Patients [PDF]

, 2008
Andrea Pasini, Ulisse Garbin, Chiara Stranieri, Veronica Boccioletti, Chiara Mozzini, Stefania Manfro, Anna Maria Fratta Pasini, Mattia Cominacini, Luciano Cominacini, M. Cominacini, L. Cominacini   +10 more
openalex   +1 more source